Also found in: Wikipedia.
an antineoplastic agent used in the palliative treatment of ovarian carcinoma. It is structurally related to an alkylating agent but does not act as one; its exact mechanism is unknown. Administered orally.
altretamine/al·tret·amine/ (al-tret´ah-mēn) an antineoplastic agent used in the palliative treatment of ovarian cancer.
an antineoplastic agent.
indications It is used for the palliative treatment of recurrent, persistent ovarian cancer after induction therapy agent.
contraindications< Known hypersensitivity to this drug, severe bone marrow depression, severe neurological toxicity, and pregnancy prohibit its use.
adverse effects Among the more serious adverse reactions are hepatic toxicity, leukopenia, thrombocytopenia, and anemia.
altretamineHexalen Oncology An alkylating anticancer agent. See Chemotherapy.
altretamineAn anticancer drug used to treat advanced caner of the ovary.
an antineoplastic agent, similar to tretamine.